New diabetes clinical trial: A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus

Published on: June 13, 2019 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Placebo;   Drug: PF-06882961
Sponsor:   Pfizer
Not yet recruiting